The Company was incorporated in the Cayman Islands as an exempted company with limited liability on December 2, 2015. The Company listing at Hong Kong stock exchange on February 19, 2019.
The Company is an investment holding company. The Company's subsidiaries are principally engaged in research and development of highly complex biopharmaceutical products.
Headquarters
1000 Zhangheng Road, Building 25, Pudong New District
Shanghai; Shanghai;
Postal Code: 201203
Contact Details: Purchase the Cstone Pharmaceuticals report to view the information.
Website: http://www.cstonepharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service